Ruxolitinib as first-line treatment in secondary hemophagocytic lymphohistiocytosis: A second experience

Inuk Zandvakili, Caitlin B. Conboy, Ayed O. Ayed, Elizabeth J. Cathcart-Rake, Ayalew Tefferi

Research output: Contribution to journal › Letter › peer-review

29 Scopus citations

Fingerprint

Dive into the research topics of 'Ruxolitinib as first-line treatment in secondary hemophagocytic lymphohistiocytosis: A second experience'. Together they form a unique fingerprint.